Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
AssigneeArizona Board of Regents on Behalf of the University of Arizona
InventorsMac E. Hadley, Victor J. Hruby, Shubh D. Sharma
Life of this patent
Estimating the term…
Abstract
Cyclic lactam peptides, seven amino acids in length, having D-2'-naphthylalanine (D-2'-Nal) or D-para-iodo-phenylalanine D-(p-I)Phe at position 4 of the peptide provided potent and specific antagonists of the two neural melanocortin receptors and of the peripheral receptor. In particular, the peptide ##STR1## was found to be a potent antagonist of the MC3 and MC4 receptors with partial agonist activity, and a full agonist of the MC1 and MC5 receptors; the peptide ##STR2## was found to be a potent antagonist of the MC3 and MC4 receptors with partial agonist activity. Both peptides have antagonist activities in the classical frog skin bioassay for pigmentation at the MC1 receptor.
Claims3
A cyclic peptide selected from the group consisting of:
- ##STR10##
Dependencies are inferred from the claim text.